Brief: Valbiotis Presents Additional Positive Results From Heart Clinical Study On Totum•070
Oct 3 (Reuters) - Valbiotis SA ALVAL.PA :
* VALBIOTIS PRESENTS ADDITIONAL POSITIVE RESULTS FROM THE
HEART
CLINICAL STUDY ON TOTUM•070 FOR HYPERCHOLESTEROLEMIA
* COMPANY CONFIRMS ITS OBJECTIVE OF MARKETING PRODUCT BY
FIRST
HALF OF 2024 AT LATEST AND IS INTENSIFYING ITS DISCUSSIONS WITH
MAJOR PLAYERS IN HEALTH AND NUTRITION SECTORS
Source text for Eikon: ID:nBw8XJsc1a
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Valbiotis SA
See all newsBrief: Valbiotis Announces Creation By Chinese JV Of Subsidiary In Singapore
French and Benelux stocks-Factors to watch
Brief: Valbiotis FY Operating Profit Eur -9.5 Mln
Brief: Valbiotis Launches Capital Increase For Gross Amount Of Nearly EUR 6.9 Mln
Brief: Valbiotis Signs Strategic Agreements With Two Pharmaceutical Groups